홈 > 시장보고서 > 의약품 > 감염질환

시장보고서

상품코드

1624233

단핵구증 진단 시장 규모 및 예측 : 세계 및 지역 점유율, 동향, 성장 기회 분석 리포트 - 유형별, 최종사용자별, 지역별

Mononucleosis Diagnostic Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User, and Geography

발행일: 2024년 11월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 210 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

The Insight Partners의 최신 조사 리포트 '단핵구증 진단 시장 예측(-2031년) : 세계 분석 - 유형별, 최종사용자별, 지역별'에 따르면 시장은 2023년 1억 5,144만 달러에서 성장하며, 2031년에는 2억 2,215만 달러에 달할 것으로 예측되며, 2023-2031년에 CAGR 4.9%를 기록할 것으로 예측됩니다. 청소년 인구의 높은 위험도, 단핵구증에 대한 건강 인식과 지식 증가는 단핵구증 진단 시장 규모 확대에 기여하고 있습니다. 그러나 기존 진단 검사의 낮은 정확도는 단핵구증 진단 시장의 성장을 저해하는 요인으로 작용하고 있습니다. 또한 단핵구증 진단의 분자진단학의 발전은 향후 수년간 새로운 단핵구증 진단 시장 동향을 가져올 것으로 예상됩니다.

매출액 기준으로는 북미가 2023년 단핵구증 진단 시장을 장악했습니다. 예측 기간 중에도 세계 시장을 독점할 것으로 추정됩니다. 미국은 세계 최대 단핵구증 진단 시장이며, 예측 기간 중에도 시장을 지배할 것으로 예상됩니다. 미국 단핵구증 진단 시장의 성장은 기술 발전, 인식 개선, 효과적인 질병 관리 전략에 대한 끊임없는 수요에 기인합니다. 미국 국립보건원에 따르면 미국에서는 매년 125,000건의 전염성 단핵구증 환자가 발생합니다. 이러한 환자 수로 인해 엡스타인-바 바이러스(EBV)로 인한 단핵구증에 대한 인식이 높아지면서 신속하고 정확한 진단 테스트 키트, 소모품 및 서비스에 대한 수요가 증가하고 있습니다. 미국내 의료 서비스 프로바이더들이 사용하는 다양한 검사 방법에는 항체 검출에 기반한 혈청학적 검사, 바이러스 DNA 식별에 초점을 맞춘 분자 검사 등이 있습니다. 미국 단핵구증 진단 시장 경쟁 구도는 Abbott Laboratories, Roche Diagnostics, Siemens Healthineers 등이 주도하고 있습니다. 이들 기업은 제품 라인업을 강화하고 시장에서의 입지를 확대하기 위해 기술 혁신과 제휴에 투자하고 있습니다.

단핵구증 진단 시장 분석

POC 검사의 개발은 향후 시장 기회를 가져올 것입니다.

현장진단(POC) 검사는 환자의 치료 현장 또는 그 근처에서 신속한 진단을 가능하게 하여 의료진이 즉각적인 임상적 판단을 내리고 환자의 결과를 개선할 수 있도록 합니다. 기존 임상 검사는 결과가 나오기까지 몇 시간에서 며칠이 걸리는 경우가 많아 치료가 지연되거나 증상이 악화될 수 있습니다. 반면, POC 검사는 몇 분 안에 결과를 얻을 수 있으며, 적시에 개입할 수 있습니다. 조기 진단은 합병증을 줄이고 환자의 편안함을 증가시킬 수 있으므로 단핵구증과 같은 질병에 있으며, 신속한 결과는 특히 중요하며, POC 검사는 외래 진료소, 응급실, 재택 치료 등 다양한 의료 환경에서 시행할 수 있습니다. 검사 인프라가 제한적인 지역이나 의료 자원이 부족한 지방에서는 접근성이 특히 유용하며, POC 검사의 형태로 진단 능력을 환자에게 더 가까이 가져와 더 많은 사람들이 적시에 진단과 적절한 치료를 받을 수 있으며, 의료 서비스의 범위를 넓힐 수 있습니다. 또한 이러한 유형의 테스트는 환자가 신속하게 결과를 받고 다음 단계에 대해 의료 서비스 프로바이더와 논의할 수 있으므로 더 많은 참여를 촉진합니다.

POC 검사는 대규모 검사 인프라를 필요로 하지 않기 때문에 기존 검사실 검사에 비해 비용 효율적이며, 결과적으로 전체 의료 시스템 비용을 낮출 수 있습니다. 단핵구증 검사의 저렴한 가격은 특히 의료 서비스를 충분히 받지 못하는 환자층 등 보다 광범위한 환자 접근성을 더욱 촉진할 수 있습니다. 최근 바이오센서 및 마이크로플루이딕스 기술의 발전으로 민감도와 특이도가 향상된 보다 정교한 현장진단(POC) 검사의 개발이 가속화되고 있습니다. 이러한 기술 혁신은 단핵구증 검출에 있으며, POC 검사의 신뢰성을 보장하고 있으며, POC 검사 키트를 제공하는 단핵구증 진단 시장 기업으로는 SEKISUI Diagnostics(OSOM Mono Test), Abbott(Clearview Mono), Cardinal Health(Cardinal Health) 등이 있습니다. Cardinal Health(Cardinal Health MONO(Mononucleosis) II Rapid Test) 등이 있습니다. 이처럼 POC 검사의 개발은 단핵구증 진단 시장의 기업에게 실질적인 성장 기회를 창출하고 있습니다.

단핵구증 진단 시장 보고서 세분화 분석

단핵구증 진단 시장의 분석에 기여한 주요 부문은 유형 및 최종사용자입니다.

유형별로 단핵구증 진단 시장은 앱스타인 바 바이러스 항체 검사, 전혈구 계산 검사, 모노스팟 검사로 구분되며, 2023년 단핵구증 진단 시장은 모노스팟 검사 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다.

최종사용자별로 단핵구증 진단 시장은 병원, 연구소, 기타로 분류되며, 2023년에는 병원 부문이 시장을 장악할 것으로 예상됩니다.

단핵구증 진단 시장 경쟁 구도 및 주요 발전 상황

Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc, Launch Diagnostics Ltd, Biorex Diagnostics, ZEUS Scientific은 단핵구증 진단 시장에서 사업을 도입하고 있는 주요 기업입니다.

유엔아동기금(UNICEF), 국립의학도서관, 질병통제예방센터(CDC), 국립보건원, 캐나다 통계청, 연방통계청(Destatis) 등은 단핵구증 진단 시장 보고서 작성시 참고한 1차 및 2차 정보입니다.

단핵구증 진단 시장 - 주요 시장 역학
시장 성장 촉진요인
- 청소년층에서의 하이리스크
- 단핵구증에 관한 건강 의식과 지식의 증가
시장 성장 억제요인
- 기존 진단 검사의 낮은 정도
시장 기회
- POC(Point of Care) 검사의 개발
향후 동향
- 분자진단학의 진보
촉진요인과 억제요인의 영향

제6장 단핵구증 진단 시장 : 세계 시장 분석

단핵구증 진단 시장 매출, 2021-2031년
단핵구증 진단 시장 예측 분석

제7장 단핵구증 진단 시장 분석 - 유형별

Monospot Test
Epstein Barr Virus 항체 검사
전혈구수검사

제8장 단핵구증 진단 시장 분석 - 최종사용자별

병원
연구소
기타

제9장 단핵구증 진단 시장 분석 - 지역별

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 아시아태평양의 기타 국가
중남미
- 브라질
- 아르헨티나
- 기타 중남미
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카

제10장 업계 상황

단핵구증 진단 시장에서의 성장 전략
유기적 성장 전략
무기적 성장 전략

제11장 기업 개요

Abbott Laboratories
Arlington Scientific Inc
Bio-Rad Laboratories Inc
Cardinal Health Inc
Meridian Bioscience Inc
Sekisui Diagnostics LLC
Thermo Fisher Scientific Inc
QuidelOrtho Corp
F. Hoffmann-La Roche Ltd
QIAGEN NV
Hologic Inc
bioMerieux SA
DiaSorin SpA
Immunostics Inc.
Launch Diagnostics Ltd
Biorex Diagnostics
ZEUS Scientific

제12장 부록

KSA 25.02.05

According to our new research study on "Mononucleosis Diagnostic Market Forecast to 2031 -Global Analysis - by Type, End User, and Geography," the market is anticipated to grow from US$ 151.44 million in 2023 and is projected to reach US$ 222.15 million by 2031; it is expected to register a CAGR of 4.9% during 2023-2031. High risk among the adolescent population, and the rising health awareness and knowledge about mononucleosis are contributing to the growing mononucleosis diagnostic market size. However, the low accuracy of existing diagnostic tests hampers the mononucleosis diagnostic market growth. Further, advancements in molecular diagnostics in mononucleosis diagnostic are expected to bring in new mononucleosis diagnostic market trends in the coming years.

In terms of revenue, North America dominated the mononucleosis diagnostic market in 2023. It is estimated to dominate the global market during the forecast period. The US is the largest market for mononucleosis diagnostics in the world, and it is estimated to dominate the market during the forecast period as well. The mononucleosis diagnostic market growth in the US is attributed to technological advancements, increased awareness, and a constant need for effective disease management strategies. According to the National Institutes of Health, the US records ~125,000 cases of infectious mononucleosis every year. Owing to such a high number, the awareness of the mononucleosis caused by the Epstein-Barr virus (EBV) is also on the rise in the country, which bolsters the demand for rapid and accurate diagnostic test kits, consumables, and services. Various testing methods adopted by healthcare providers in the country include serological tests based on antibody detection and molecular tests focused on viral DNA identification. The competitive landscape of the mononucleosis diagnostics market in the US is dominated by companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. These companies invest in innovation and collaborations to enhance their product offerings and expand their market presence.

Mononucleosis Diagnostic Market Analysis

Development of Point-of-Care Testing to Provide Market Opportunities in Future

POC testing allows for rapid diagnosis at or near the site of patient care, enabling healthcare providers to make immediate clinical decisions and improve patient outcomes. Traditional laboratory tests often require hours or days to generate results, which can delay treatment and worsen symptoms. In contrast, POC tests can deliver results within minutes, facilitating timely intervention. The rapid turnaround is especially crucial for conditions such as mononucleosis, as early diagnosis can reduce complications and enhance patient comfort. POC testing can be implemented in various healthcare settings, including outpatient clinics, emergency departments, and home care settings. The accessibility is particularly beneficial in areas with limited laboratory infrastructure or in rural regions with insufficient healthcare resources. Bringing diagnostic capabilities closer to patients in the form of POC testing ensures that more individuals receive timely diagnoses and appropriate care, thereby broadening the reach of healthcare services. Moreover, this type of testing promotes greater engagement, as patients can receive their results quickly and discuss the next steps with their healthcare providers.

POC testing can be more cost-effective compared to traditional laboratory testing as they don't need extensive laboratory infrastructure, in turn lowering the overall costs for healthcare systems. The affordability of mononucleosis testing further drives its accessibility to a broader range of patients, especially in underserved populations. Recent advancements in biosensors and microfluidic technologies are driving the development of more sophisticated POC tests with improved sensitivity and specificity. These innovations ensure the reliability of POC tests in detecting mononucleosis. Mononucleosis diagnostic market players offering POC test kits include SEKISUI Diagnostics (OSOM Mono Test), Abbott (Clearview Mono), and Cardinal Health [Cardinal Health MONO (Mononucleosis) II Rapid Test]. Thus, the development of POC testing generates substantial growth opportunities for the mononucleosis diagnostics market players.

Mononucleosis Diagnostic Market Report Segmentation Analysis

Key segments that contributed to the derivation of the mononucleosis diagnostic market analysis are type and end user.

Based on type, the mononucleosis diagnostic market is segmented into Epstein Barr Virus antibody test, complete blood count test, and monospot test. The monospot test segment held the largest mononucleosis diagnostic market share of the market in 2023.

In terms of end user, the mononucleosis diagnostic market is categorized into hospitals, laboratories, and others. The hospitals segment dominated the market in 2023.

Mononucleosis Diagnostic Market: Competitive Landscape and Key Developments

Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc., Launch Diagnostics Ltd, Biorex Diagnostics, and ZEUS Scientific are among the key companies operating in the mononucleosis diagnostic market.

The United Nations Children's Fund (UNICEF), National Library of Medicine, Centers for Disease Control and Prevention (CDC), National Institutes of Health, Statistics Canada, Federal Statistical Office (Destatis) are among the primary and secondary sources referred to while preparing the mononucleosis diagnostic market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Mononucleosis Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Mononucleosis Diagnostics Market - Key Market Dynamics

5.1 Mononucleosis Diagnostics Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 High Risk among Adolescent Population
- 5.2.2 Rising Health Awareness and Knowledge About Mononucleosis
5.3 Market Restraints
- 5.3.1 Low Accuracy of Existing Diagnostic Tests
5.4 Market Opportunities
- 5.4.1 Development of Point-of-Care Testing
5.5 Future Trends
- 5.5.1 Advancements in Molecular Diagnostics
5.6 Impact of Drivers and Restraints:

6. Mononucleosis Diagnostics Market - Global Market Analysis

6.1 Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
6.2 Mononucleosis Diagnostics Market Forecast Analysis

7. Mononucleosis Diagnostics Market Analysis - by Type

7.1 Monospot Test
- 7.1.1 Overview
- 7.1.2 Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
7.2 Epstein Barr Virus Antibody Test
- 7.2.1 Overview
- 7.2.2 Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
7.3 Complete Blood Count Test
- 7.3.1 Overview
- 7.3.2 Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Mononucleosis Diagnostics Market Analysis - by End User

8.1 Hospital
- 8.1.1 Overview
- 8.1.2 Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
8.2 Laboratories
- 8.2.1 Overview
- 8.2.2 Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Mononucleosis Diagnostics Market - Geographical Analysis

9.1 North America
- 9.1.1 North America Mononucleosis Diagnostics Market Overview
- 9.1.2 North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
- 9.1.3 North America: Mononucleosis Diagnostics Market Breakdown, by Type
  - 9.1.3.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
- 9.1.4 North America: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.1.4.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.1.5 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.1.5.1 United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.1.5.1.1 United States: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.1.5.1.2 United States: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.1.5.2 Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.1.5.2.1 Canada: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.1.5.2.2 Canada: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.1.5.3 Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.1.5.3.1 Mexico: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.1.5.3.2 Mexico: Mononucleosis Diagnostics Market Breakdown, by End User
9.2 Europe
- 9.2.1 Europe Mononucleosis Diagnostics Market Overview
- 9.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  - 9.2.2.1 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
  - 9.2.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.2.3 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.2.3.1 Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.1.1 Germany: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.1.2 Germany: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.2 United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.2.1 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.2.2 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.3 France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.3.1 France: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.3.2 France: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.4 Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.4.1 Italy: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.4.2 Italy: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.5 Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.5.1 Spain: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.5.2 Spain: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.6 Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.6.1 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.6.2 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by End User
9.3 Asia Pacific
- 9.3.1 Asia Pacific Mononucleosis Diagnostics Market Overview
- 9.3.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  - 9.3.2.1 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
  - 9.3.2.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.3.3 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.3.3.1 China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.1.1 China: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.1.2 China: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.2 Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.2.1 Japan: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.2.2 Japan: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.3 India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.3.1 India: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.3.2 India: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.4 Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.4.1 Australia: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.4.2 Australia: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.5 South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.5.1 South Korea: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.5.2 South Korea: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.6 Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.6.1 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.6.2 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by End User
9.4 South and Central America
- 9.4.1 South and Central America Mononucleosis Diagnostics Market Overview
- 9.4.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  - 9.4.2.1 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
  - 9.4.2.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.4.3 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.4.3.1 Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.4.3.1.1 Brazil: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.4.3.1.2 Brazil: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.4.3.2 Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.4.3.2.1 Argentina: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.4.3.2.2 Argentina: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.4.3.3 Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.4.3.3.1 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.4.3.3.2 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by End User
9.5 Middle East and Africa
- 9.5.1 Middle East and Africa Mononucleosis Diagnostics Market Overview
- 9.5.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  - 9.5.2.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
  - 9.5.2.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.5.3 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.5.3.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.5.3.2 Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.5.3.2.1 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.5.3.2.2 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.5.3.3 South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.5.3.3.1 South Africa: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.5.3.3.2 South Africa: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.5.3.4 United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.5.3.4.1 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.5.3.4.2 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.5.3.5 Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.5.3.5.1 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.5.3.5.2 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by End User

10. Industry Landscape

10.1 Overview
10.2 Growth Strategies in Mononucleosis Diagnostic Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Abbott Laboratories
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Arlington Scientific Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Bio-Rad Laboratories Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Cardinal Health Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Meridian Bioscience Inc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Sekisui Diagnostics LLC
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Thermo Fisher Scientific Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 QuidelOrtho Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 F. Hoffmann-La Roche Ltd
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 QIAGEN NV
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 Hologic Inc
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
11.12 bioMerieux SA
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
11.13 DiaSorin SpA
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments
11.14 Immunostics Inc.
- 11.14.1 Key Facts
- 11.14.2 Business Description
- 11.14.3 Products and Services
- 11.14.4 Financial Overview
- 11.14.5 SWOT Analysis
- 11.14.6 Key Developments
11.15 Launch Diagnostics Ltd
- 11.15.1 Key Facts
- 11.15.2 Business Description
- 11.15.3 Products and Services
- 11.15.4 Financial Overview
- 11.15.5 SWOT Analysis
- 11.15.6 Key Developments
11.16 Biorex Diagnostics
- 11.16.1 Key Facts
- 11.16.2 Business Description
- 11.16.3 Products and Services
- 11.16.4 Financial Overview
- 11.16.5 SWOT Analysis
- 11.16.6 Key Developments
11.17 ZEUS Scientific
- 11.17.1 Key Facts
- 11.17.2 Business Description
- 11.17.3 Products and Services
- 11.17.4 Financial Overview
- 11.17.5 SWOT Analysis
- 11.17.6 Key Developments

12. Appendix

12.1 About the Insight Partners
12.2 Glossary of Terms for Mononucleosis Diagnostics Market

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,424,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,450

￦ 9,312,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450

￦ 12,200,000

※ 부가세 별도